Key Developments in the Potential of Curcumin for the Treatment of Peripheral Neuropathies
- PMID: 33023197
- PMCID: PMC7600446
- DOI: 10.3390/antiox9100950
Key Developments in the Potential of Curcumin for the Treatment of Peripheral Neuropathies
Abstract
Peripheral neuropathies (PN) can be triggered after metabolic diseases, traumatic peripheral nerve injury, genetic mutations, toxic substances, and/or inflammation. PN is a major clinical problem, affecting many patients and with few effective therapeutics. Recently, interest in natural dietary compounds, such as polyphenols, in human health has led to a great deal of research, especially in PN. Curcumin is a polyphenol extracted from the root of Curcuma longa. This molecule has long been used in Asian medicine for its anti-inflammatory, antibacterial, and antioxidant properties. However, like numerous polyphenols, curcumin has a very low bioavailability and a very fast metabolism. This review addresses multiple aspects of curcumin in PN, including bioavailability issues, new formulations, observations in animal behavioral tests, electrophysiological, histological, and molecular aspects, and clinical trials published to date. The, review covers in vitro and in vivo studies, with a special focus on the molecular mechanisms of curcumin (anti-inflammatory, antioxidant, anti-endoplasmic reticulum stress (anti-ER-stress), neuroprotection, and glial protection). This review provides for the first time an overview of curcumin in the treatment of PN. Finally, because PN are associated with numerous pathologies (e.g., cancers, diabetes, addiction, inflammatory disease...), this review is likely to interest a large audience.
Keywords: anti-ER-stress; anti-inflammatory; antioxidant; clinical trial; curcumin; peripheral neuropathy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
Cited by
-
Anti-Inflammatory and Antioxidant Properties of Plant Extracts.Antioxidants (Basel). 2021 Jun 7;10(6):921. doi: 10.3390/antiox10060921. Antioxidants (Basel). 2021. PMID: 34200199 Free PMC article.
-
Metabolites of Moringa oleifera Activate Physio-Biochemical Pathways for an Accelerated Functional Recovery after Sciatic Nerve Crush Injury in Mice.Metabolites. 2022 Dec 9;12(12):1242. doi: 10.3390/metabo12121242. Metabolites. 2022. PMID: 36557280 Free PMC article.
-
Curcumin reduced fat accumulation in Caenorhabditis elegans.Curr Res Food Sci. 2021 Aug 14;4:551-556. doi: 10.1016/j.crfs.2021.08.005. eCollection 2021. Curr Res Food Sci. 2021. PMID: 34458861 Free PMC article.
-
Protective effects of Boswellia and Curcuma extract on oxaliplatin-induced neuropathy via modulation of NF-κB signaling.Toxicol Rep. 2024 Oct 20;13:101781. doi: 10.1016/j.toxrep.2024.101781. eCollection 2024 Dec. Toxicol Rep. 2024. PMID: 39512239 Free PMC article.
-
The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes: a randomized double-blind clinical trial.Nutr J. 2025 Jul 18;24(1):115. doi: 10.1186/s12937-025-01184-8. Nutr J. 2025. PMID: 40682175 Free PMC article. Clinical Trial.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources